Holen Sie sich die Stockscreener-App
76.03
0.04%
-0.07
Schlusskurs vom Vortag:
$76.10
Offen:
$75.77
24-Stunden-Volumen:
251.33K
Relative Volume:
0.27
Marktkapitalisierung:
$4.94B
Einnahmen:
$1.54B
Nettoeinkommen (Verlust:
$233.56M
KGV:
22.58
EPS:
3.3669
Netto-Cashflow:
$348.64M
1W Leistung:
+4.08%
1M Leistung:
+4.84%
6M Leistung:
+44.35%
1J Leistung:
-16.33%
1-Tages-Spanne:
$75.12
$76.71
1-Wochen-Bereich:
$73.13
$77.71
52-Wochen-Spanne:
$47.25
$108.91
Lantheus Holdings Inc Stock (LNTH) Company Profile
Firmenname
Lantheus Holdings Inc
Sektor
Telefon
978 671-8001
Adresse
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Compare LNTH vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
75.94 | 4.95B | 1.54B | 233.56M | 348.64M | 3.3669 |
TAK
Takeda Pharmaceutical Co Adr
|
18.20 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
118.24 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.935 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.68 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
555.02 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-26 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2025-12-12 | Hochstufung | Truist | Hold → Buy |
| 2025-10-08 | Herabstufung | Goldman | Buy → Neutral |
| 2025-08-12 | Herabstufung | Truist | Buy → Hold |
| 2024-12-18 | Eingeleitet | Goldman | Buy |
| 2024-09-03 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-07-10 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-12-18 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | Eingeleitet | TD Cowen | Outperform |
| 2023-09-29 | Eingeleitet | William Blair | Outperform |
| 2023-03-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-11-30 | Eingeleitet | SVB Leerink | Outperform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-05-09 | Eingeleitet | B. Riley Securities | Buy |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2021-02-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-29 | Fortgesetzt | Jefferies | Buy |
| 2019-08-16 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | Bestätigt | RBC Capital Mkts | Outperform |
| 2016-09-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2016-02-24 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-12-11 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | Eingeleitet | Credit Suisse | Outperform |
| 2015-07-20 | Eingeleitet | Jefferies | Buy |
| 2015-07-20 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2015-07-20 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-20 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Lantheus Holdings Inc Aktie (LNTH) Neueste Nachrichten
LANTHEUS HOLDINGS INC (1LNTH.MI) options chain - Yahoo Finance Australia
Lantheus Holdings, Inc. (LNTH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Forecast Cut: Whats the MACD signal for Lantheus Holdings Inc2026 Support & Resistance & Detailed Earnings Play Strategies - baoquankhu1.vn
LNTH Stock Price, Quote & Chart | LANTHEUS HOLDINGS INC (NASDAQ:LNTH) - ChartMill
Lantheus (NASDAQ: LNTH) CCO logs PSU vesting, tax withholding - Stock Titan
Lantheus Holdings, Inc. (LNTH) Stock Forecasts - Yahoo Finance
Lantheus Holdings, Inc. (LNTH) stock price, news, quote and history - Yahoo Finance UK
Bronstein, Gewirtz & Grossman, LLC Encourages Lantheus Holdings, Inc. (LNTH) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Jefferies Lifts PT on Lantheus Holdings (LNTH) to $110 From $105 – Here’s Why - Insider Monkey
Trading Systems Reacting to (LNTH) Volatility - Stock Traders Daily
Risk Analysis: How does Lantheus Holdings Inc compare to its peersEarnings Summary Report & AI Enhanced Trading Signals - baoquankhu1.vn
Portfolio Update: What analysts say about Lantheus Holdings Inc stockGDP Growth & Safe Entry Momentum Tips - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lantheus Holdings, Inc. (LNTH) And Encourages Shareholders to Connect - ACCESS Newswire
Assenagon Asset Management S.A. Trims Position in Lantheus Holdings, Inc. $LNTH - MarketBeat
11 High Growth Healthcare Stocks to Buy Now - Insider Monkey
Lantheus says FDA extended review period for radioactive diagnostic kit - MSN
Lantheus (NASDAQ:LNTH) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat
Vanguard disaggregates holdings; Vanguard subsidiaries to report LNTH positions (LNTH) - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lantheus Holdings, Inc. (LNTH) And Encourages Shareholders to Reach Out - ACCESS Newswire
Insider Buy: Is Lantheus Holdings Inc exposed to political risk2026 Recap & Safe Entry Point Alerts - baoquankhu1.vn
William Blair, Jefferies Maintain LNTH Lantheus Holdings March 2026: Outperform Buy - Meyka
Nuclear Medicine (Radiopharmaceuticals) Market Set for Strong Growth at 9.50% CAGR Through 2034: DelveInsight | Lantheus, GE Healthcare, Novartis, Sotera Health and Others - Barchart.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lantheus Holdings, Inc. (LNTH) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
CWA Asset Management Group LLC Makes New $1.67 Million Investment in Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus Holdings, Inc. (LNTH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Lantheus to sell SPECT Business to SHINE Technologies - MSN
LNTH Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges LNTH Investors with Losses to Contact the Firm - The National Law Review
Class Action Announcement for Lantheus Holdings, Inc. Investors - The National Law Review
Form DEF 14A LANTHEUS HOLDINGS For: 20 March - Investing.com
Lantheus Holdings, Inc. ($LNTH) Former CEO 2025 Pay Revealed - Quiver Quantitative
[ARS] Lantheus Holdings, Inc. SEC Filing - Stock Titan
Lantheus (NASDAQ: LNTH) 2026 proxy outlines board elections, pay and equity plan - Stock Titan
How Lantheus Holdings Inc. (LNTH) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Lantheus Holdings Inc (LNTH) Trading Down 3.37% on Mar 19 - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lantheus Holdings, Inc. (LNTH) And Encourages Investors to Connect - ACCESS Newswire
Aug Weekly: Will Lantheus Holdings Inc outperform the market in YEAR2026 Key Highlights & Scalable Portfolio Growth Methods - baoquankhu1.vn
Why Lantheus Holdings Stock Popped by Almost 12% Last Month - AOL.com
Lantheus price target raised to $82 from $80 at Truist - MSN
Lantheus Holdings Q4 2025 earnings preview - MSN
Citizens reiterates Lantheus stock rating after FDA extends review By Investing.com - Investing.com Canada
FDA extends review of Lantheus’ neuroendocrine tumor drug By Investing.com - Investing.com South Africa
Lantheus says FDA pushed deadline for reviewing its tumor diagnostic kit application - MSN
Lantheus Holdings, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Lantheus stock holds Outperform at William Blair after FDA delay By Investing.com - Investing.com India
US FDA extends review of Lantheus’ diagnostic imaging kit by three months - WKZO
Lantheus stock holds Outperform at William Blair after FDA delay - Investing.com
Lantheus Says FDA Pushed Deadline For Reviewing Its Tumor Diagnostic Kit Application - Asianet Newsable
Lantheus (LNTH) Drug Application Review Extended by FDA - GuruFocus
Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs) - Bitget
Jefferies Maintains Buy on Lantheus Holdings (LNTH) Mar 17 2026 - Meyka
US FDA extends review of Lantheus' diagnostic imaging kit by three months - Yahoo Finance
Finanzdaten der Lantheus Holdings Inc-Aktie (LNTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):